Nextech Invest Ltd.

About The Fund

Nextech Invest Ltd. is an investment firm with a focused strategy in the biotech industry, particularly in oncology. With an inception date of 1998 and headquartered in Zurich, Switzerland, they specialize in venture capital and private equity investments, catering to early, mid, and late-stage as well as emerging growth companies. Their expertise also covers incorporation, spin-outs, reverse-takeover, and PIPE transactions. A key criterion for Nextech's investment is the availability of preclinical animal models data demonstrating drug efficacy or a device prototype that meets necessary requirements. Their sectoral reach includes information technology and healthcare, predominantly seeking innovative companies developing cancer drugs and diagnostics. Their interest spans life science and enabling technologies, with particular attention to interdisciplinary technical and scientific projects, therapies, diagnostics, medical technologies, and services. Nextech operates with a global perspective, targeting companies based in Africa, Middle East, Asia, North America, and Europe, focusing on regions including Switzerland, Germany, and adjacent areas. Open to co-investments, they consider opportunities throughout Europe. Investment amounts range between CHF 1 million and CHF 5 million per financing round. They strive for a hands-on approach by seeking board positions in their portfolio companies. Nextech plans exits usually via trade sale, ideally within a three-year timeframe. Their tagline 'Finding and fueling tomorrow’s advances in precision medicine' reflects their commitment to driving advancements in biotech. They prioritize nurturing their portfolio companies through critical stages of scientific validation and value creation, aiming to accelerate the development of transformative cancer medicines globally.